ALTSHULER DAVID sold VRTX

February 21, 2024 · Form 4 insider transaction

ALTSHULER DAVID sold 3,002 shares of Vertex Pharmaceuticals Incorporated at $421.77 per share, a transaction worth $1.27M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
3,002
Price
$421.77
Total value
$1.27M
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 21, 2024
Filing dateFebruary 23, 2024
Shares owned after34,022
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 5/10/2023.

View the original Form 4 on SEC EDGAR